Ibrutinib increases miR-181a/b in leukemic cells from patients with chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Ramassone A 

PROVIDER: S-EPMC12506510 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature